Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H<sub>2</sub>S for Anti-Inflammation and Anticalcification

Lijuan Wang,Fubang Liang,Yushuang Shang,Xu Liu,Meng Yin,Jian Shen,Jiang Yuan
DOI: https://doi.org/10.1021/acsami.3c15176
IF: 9.5
2023-01-01
ACS Applied Materials & Interfaces
Abstract:Vascular complications caused by diabetes impair the activities of endothelial nitric oxide synthase (eNOS) and cystathionine gamma-lyase (CSE), resulting in decreased physiological levels of nitric oxide (NO) and hydrogen sulfide (H2S). The low bioavailability of NO and H2S hinders the endothelialization of vascular grafts. In this study, endothelium-mimicking bilayer vascular grafts were designed with spatiotemporally controlled dual releases of NO and H2S for in situ endothelialization and angiogenesis. Keratin-based H2S donor was synthesized and electrospun with poly(l-lactide-co-epsilon-caprolactone) (PLCL) as the outer layer of the graft to release H2S. Hyaluronic acid, one of the major glycosaminoglycans in endothelial glycocalyx, was complexed with Cu ions as the inner layer to mimic glutathione peroxidase (GPx) and maintain long-term physiological NO flux. The synergistic effects of NO and H2S of bilayer grafts selectively promoted the regeneration and migration of human umbilical vascular endothelial cells (HUVECs), while inhibiting the overproliferation of human umbilical artery smooth muscle cells (HUASMCs). Bilayer grafts could effectively prevent vascular calcification, reduce inflammation, and alleviate endothelial dysfunction. The in vivo study in a rat abdominal aorta replacement model for 1 month showed that the graft had a good patency rate and had potential for vascular remodeling in situ.
What problem does this paper attempt to address?